HOUSE BILL 1400

Sponsored By:

Delegates Conroy, Benson, Bohanan, Cole, Cane, DeCarlo, James, Kagan, K. Kelly, Malone, and Pitkin

Entitled:

Fair Pricing for Prescription Drugs - Maximum Allowable Prices

Synopsis:

Providing that, based on specified criteria, a manufacturer, wholesaler, or retailer may not charge a specified price for a prescription drug sold in Maryland; establishing specified maximum pricing criteria for a prescription drug sold in the State by a manufacturer; establishing specified maximum pricing criteria for a prescription drug sold in the State by a wholesaler; establishing specified maximum pricing criteria for a prescription drug sold in the State by a retailer; etc.

History by Legislative Date

House Action

2/26

First Reading House Rules and Executive Nominations

3/5

Re-referred Economic Matters & Environmental Matters

3/7

Hearing 3/15 at 1:00 p.m.

3/21

Unfavorable Report by Economic Matters

Senate Action

No Action

Sponsored by:

Delegate Mary A. Conroy, District 23

Delegate Joanne C. Benson, District 24

Delegate John L. Bohanan, Jr., District 29B

Delegate Rudolph C. Cane, District 37A

Delegate William H. Cole, IV, District 47A

Delegate Diane DeCarlo, District 6

Delegate Mary-Dulany James, District 34

Delegate Cheryl C. Kagan, District 17

Delegate Kevin Kelly, District 1B

Delegate James E. Malone, Jr., District 12A

Delegate Joan B. Pitkin, District 23

Bill indexed under the following Subjects:

CONSUMER PROTECTION -see also- UNFAIR TRADE PRACTICES

DRUGS -see also- CONTROLLED DANGEROUS SUB; SUBSTANCE ABUSE

PRICES -see also- CONSUMER PRICE INDEX

Bill affects the following Statutes:

Commercial Law

( 11-1501 , 11-1502 , 11-1503 )

Documents:

Bill Text: First Reading (PDF), Third Reading, Enrolled

Fiscal Note: Available (PDF)

Amendments: None offered